Search
-
Recent Articles
Classic Articles
Subscribe
Archives
Categories
Author Archives: Kevin A. Barnes
Team Challenge Update: Napa-to-Sonoma 2010
Team Challenge Wisconsin is once again participating in the Napa-to-Sonoma Half Marathon. Although I am not running Napa-to-Sonoma this year, I am serving as a mentor for several Team Challenge participants. Each participant spends 16 weeks training to run or walk … Read the rest of this entry
Pardon our dust
Regular visitors to this website probably have already noticed that I updated the design over the weekend. The changes are intended to accomplish two things — to make the content easier to read and to reduce the time it takes … Read the rest of this entry
Is psychiatry’s bible still in the dark ages?
New Scientist recently published an article1 describing the conflict that has emerged in American psychiatry over the upcoming revised version of the DSM (Diagnostic and Statistical Manual of Mental Disorders), frequently referred to as psychiatry’s bible. From my point of … Read the rest of this entry
Is generic Remicade (Humira, etc.) in our future?
As part of $3K in 3 Weeks, here is another in a series of articles on current issues and topics related to Crohn’s disease and ulcerative colitis. Did you know that biologics1 such as Remicade, Humira, and Cimzia – used … Read the rest of this entry
Posted in $3K in 3 Weeks, Crohn's Disease, Science
Tagged biologics, Cimzia, Crohn's Disease, generic drugs, H.R. 3962, Hatch-Waxman Act, health care reform, Humira, ibd, Remicade, ulcerative colitis
Leave a comment
Research Update: The Human Gut Microbiome Initiative
As part of $3K in 3 Weeks, here is the first in a series of articles on current research initiatives related to Crohn’s disease and ulcerative colitis. The Human Gut Microbiome Initiative, based at the Genome Center of Washington University … Read the rest of this entry
